Role of Cardiac Magnetic Resonance Imaging in Valvular Heart Disease: Diagnosis, Assessment, and Management

• Published in: Current cardiology reports Vol. 20; no. 11; p. 119
• Main Authors: Mathew, Roshin C., Löffler, Adrián I., Salerno, Michael
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.11.2018
• Subjects: Cardiology; Medicine; Medicine & Public Health; Section Editor; Topical Collection on Valvular Heart Disease; Valvular Heart Disease (TL Kiefer; Mitral regurgitation; Velocity encoded imaging; Aortic regurgitation; Cardiac valve disease; Phase-contrast imaging; Cardiac magnetic resonance imaging
• ISSN: 1523-3782; 1534-3170; 1534-3170
• DOI: 10.1007/s11886-018-1057-9

Purpose of Review This article will review the current techniques in cardiac magnetic resonance imaging (CMR) for diagnosing and assessing primary valvular heart disease. Recent Findings The recent advancements in CMR have led to an increased role of this modality for qualifying and quantifying various native valve diseases. Phase-contrast velocity encoded imaging is a well-established technique that can be used to quantify aortic and pulmonic flow. This technique, combined with the improved ability for CMR to obtain accurate left and right ventricular volumetrics, has allowed for increased accuracy and reproducibility in assessing valvular dysfunction. Advancements in CMR technology also allows for improved spatial and temporal resolution imaging of various valves and their regurgitant or stenotic jets. Therefore, CMR can be a powerful tool in evaluation of native valvular heart disease. Summary The role of CMR in assessing valvular heart disease is growing and being recognized in recent guidelines. CMR has the ability to assess valve morphology along with qualifying and quantifying valvular disease. In addition, the ability to obtain accurate volumetric measurements may improve more precise management strategies and may lead to improvements in mortality and morbidity.